How to submit an abstract

Late abstract submission 24/10 – 30/10

Abstracts must be submitted through the on-line submission procedure by 31th of August 2018. (site);

Abstracts must be submitted in English and can be presented in English or in Portuguese.

Abstracts will be evaluated only if the presenting author is registered. The registration fee of the presenting author will not be waived. Participants who do not pay registration will have the ABSTRACT CANCELED.

Please note:

  • Abstracts sent by mail, e-mail or fax will not be accepted.
  • A title (in capital letters and bold) that clearly indicates the nature of the investigation needs to be provided.
  • Abbreviations should be avoided in titles but may be used in the text if they are defined at first usage.
  • Choose one primary topic listed on the website which best corresponds to the content of your abstract.
  • The length of the abstract should not exceed 4500 printable characters including title of the abstract, author details, headers, punctuation, blank spaces and references.
  • The authors’ names (family name, full first name) and places of work (institution, city, state, country, separated by a semicolon) must be shown, but omit degrees, titles, appointments, postal address and acknowledgement of support. Italicize the presenting author’s name.
  • The abstract should be structured as shown on the model file (CLICK HERE to download the model file). One table can be accepted in the abstract body. Graphics and figures will not be accepted:
  1. State the specific objective of the study
  2. State the methodsused
  3. Summarise the resultsobtained and include key data and their significance
  4. State the conclusionsreached
  5. References may be added
  • The abstract should be as informative as possible.
  • Please ensure that your abstract does not contain spelling, grammatical or scientific errors, as it will be reproduced exactly as submitted.
  • Statements such as “data will be presented” will lead to automatic rejection of the abstract.
  • Notification of acceptance or rejection by the Scientific Committee shall be made available to the reserved area of ​​the registered author by the beginning of October 2018.
  • Abstracts will be evaluated and may be selected for an oral or a poster presentation (or may be rejected).





1.1. Cell/molecular biology/pathology

1.2. Immunity and inflammation

1.3. Microbiology

1.4. Infections

1.5. Upper GI and small intestinal bleeding

1.6. Community dyspepsia

1.7. Functional upper GI disorders

1.8. Upper GI nerve-gut interactions and motility

1.9. Upper GI motility disorders

1.10. Functional upper GI disorders

1.11. Reflux disease

1.12. Barrett’s oesophagus

1.13. Oesophageal neoplasia

1.14. Paediatric oesophageal disorders

1.15. Acid peptic disease

1.16. Gastric neoplasia

1.17. Disorders caused by metabolic diseases

1.18. Upper GI vascular disorders

1.19 Other oesophageal and gastric disorders



2.1. Enterocyte biology/pathology and nutrient/water transport/electrolyte transport

2.2. Small intestinal immunology, immunity and inflammation

2.3. Microbiology

2.4. Small intestinal infections

2.5. Coeliac disease

2.6. Malabsorption syndromes and food enteropathies

2.7. Small intestinal neoplasia

2.8. Small intestinal bleeding

2.9. Vascular disorders

2.10. Small intestinal motility and nerve-gut interactions

2.11. Disorders caused by metabolic diseases

2.12. Other small intestinal disorders



3.1. Obesity

3.2. Nutrients and gut function

3.3. Enteral and parenteral nutrition

3.4. Paediatric nutrition



4.1. Basic/pathogenesis/pathology

4.2. Aetiology/epidemiology

4.3. Genetics

4.4. Diagnosis and monitoring

4.5. Treatment

4.6. Paediatric and adolescent IBD



5.1. Lower GI Immunology, immunity, inflammation (NOT IBD)

5.2. Microbiology

5.3. Lower GI infections

5.4. Lower GI bleeding

5.5. Lower GI malignant disease

5.6. Lower GI nerve-gut interactions and motility

5.7. Irritable bowel syndrome

5.8. Lower GI vascular disorders

5.9. Diverticular disease

5.10. Disorders caused by metabolic diseases

5.11. Other lower GI disorders


  1. LIVER

6.1. Molecular biology, inflammation and fibrosis

6.2. Microbiology

6.3. Regeneration, stem cells and nutrition

6.4. Metabolic/genetic disorders

6.5. Hepatotoxicity/alcohol

6.6. Cirrhosis and complications

6.7. Viral hepatitis

6.8. Immunology, autoimmune liver disease

6.9. Liver neoplasia

6.10. Vascular diseases of the liver, bile duct or pancreas

6.11. Biliary disease



7.1. Cell biology/secretion/enzymology/physiology

7.2. Pancreatitis

7.3. Pancreatic cancer

7.4. Endocrine tumors of the pancreas

7.5. Paediatric pancreatic disease